Skip to main content

Table 4 Association between KDM2A protein expression and clinical features in ccRCC

From: Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma

Parameters

n

KDM2A mRNA expression in ccRCC

P

Low, n (%)

High, n (%)

Gender

    

Male

29

1 (3.4%)

28 (96.6%)

0.181

Female

21

4 (19.0%)

17 (81.0%)

 

Age, years

    

< 60

28

3 (10.7%)

25 (89.3%)

1.000

≥ 60

22

2 (9.1%)

20 (90.9%)

 

Location

    

Left

22

2 (9.1%)

20 (90.9%)

1.000

Right

28

3 (10.7%)

25 (89.3%)

 

BMI (kg/m2)

    

< 24

20

0 (0%)

20 (100%)

0.149

≥ 24

30

5 (16.7%)

25 (83.3%)

 

Tumor size (cm)

    

≤ 7

35

5 (14.3%)

30 (85.7%)

0.304

> 7

15

0 (0%)

15 (100%)

 

Smoking

    

No

39

5 (12.8%)

34 (87.2%)

0.495

Yes

11

0 (0%)

11 (100%)

 

Thrombus of renal vein

    

No

46

5 (10.9%)

41 (89.1%)

1.000

Yes

4

0 (0%)

4 (100%)

 

TNM stage

    

T1–T2

38

5 (13.2%)

33 (86.8%)

0.440

T3–T4

12

0 (0%)

12 (100%)

 

ISUP grade

    

1–2

35

4 (11.4%)

31 (88.6%)

1.000

3–4

15

1 (6.7%)

14 (93.3%)

 

Symptoms

    

No

32

4 (12.5%)

28 (87.5%)

0.768

Yes

18

1 (5.6%)

17 (94.4%)

 

Hypertension

    

No

29

4 (13.8%)

25 (86.2%)

0.567

Yes

21

1 (4.8%)

20 (95.2%)